[<sup>89</sup>Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
Paclitaxel (PTX) treatment efficacy varies in breast cancer, yet the underlying mechanism for variable response remains unclear. This study evaluates whether human epidermal growth factor receptor 2 (HER2) expression level utilizing advanced molecular positron emission tomography (PET) imaging is co...
Main Authors: | Yun Lu, Meng Li, Adriana V. F. Massicano, Patrick N. Song, Ameer Mansur, Katherine A. Heinzman, Benjamin M. Larimer, Suzanne E. Lapi, Anna G. Sorace |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/6/1568 |
Similar Items
-
Therapeutic Response Monitoring with <sup>89</sup>Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models
by: Minwoo Kang, et al.
Published: (2022-06-01) -
[<sup>89</sup>Zr]-Atezolizumab-PET Imaging Reveals Longitudinal Alterations in PDL1 during Therapy in TNBC Preclinical Models
by: Adriana V. F. Massicano, et al.
Published: (2023-05-01) -
Current Perspectives on <sup>89</sup>Zr-PET Imaging
by: Joon-Kee Yoon, et al.
Published: (2020-06-01) -
HER3 PET Imaging: <sup>68</sup>Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to <sup>89</sup>Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
by: Sara S. Rinne, et al.
Published: (2021-09-01) -
Evaluation of <sup>68</sup>Ga-Radiolabeled Peptides for HER2 PET Imaging
by: Maxwell Ducharme, et al.
Published: (2022-11-01)